Gansu Provincial Cancer Hospital

Lanzhou 730050

4 studies enrolling now · 4 studies all time

What they study most

Chronic Lymphocytic Leukemia, Colorectal Neoplasms, Gastric Cancer, Gastroesophageal Junction Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Lymphoma, Small Lymphocytic, Monoclonal Antibody

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now